Five day intermittent vs seven day continuous 2-chlorodeoxyadenosine infusion for the treatment of hairy cell leukemia. A study by Italian Group for the Hairy Cell Leukemia

Recenti Progressi in Medicina

Volumn 89, Issue 2, 1998, Pages 68-73

  Damasio, Eugenio E ^a   Resegotti, Luigi ^b   Masoudi, Bahman ^a   Bruni, Roberta ^a   Cerri, Raffaella ^a   Isaza, Adriana ^a   Clavio, Marino ^c   Risso, Marco ^a   Rossi, Edoardo ^a   Spriano, Mauro ^a   Truini, Mauro ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b MOLINETTE HOSPITAL   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

2 chlorodeoxyadenosine; DBA44 monoclonal antibody; Hairy cell leukemia; HCI

Indexed keywords

CLADRIBINE; INTERFERON; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY DBA 44; PURINE DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; AGED; APLASTIC ANEMIA; ARTICLE; BLEEDING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG EFFICACY; DRUG INTERMITTENT THERAPY; DRUG RESPONSE; FEMALE; FEVER; HAIRY CELL LEUKEMIA; HUMAN; INFECTION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MULTICENTER STUDY; NAUSEA; RASH; RESPIRATORY DISTRESS; SPLENECTOMY;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; CLADRIBINE; DRUG ADMINISTRATION SCHEDULE; EVALUATION STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; INFUSIONS, INTRAVENOUS; LEUKEMIA, HAIRY CELL; MALE; MIDDLE AGED; TIME FACTORS;

EID: 0031914636     PISSN: 00341193     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Quesada JR, Reuben JR, Manning JT et al. Alpha interferon for induction of remission in hairy cell leukemia. N Engl J Med 1984; 310: 15-8.
2. Federico M, Chisesi T, Lauria F et al. Human lymphoblastoid interferon as initial therapy in hairy cell leukemia. A multicenter study in non splenectomized patients. Brit J Haematol 1989; 72: 54-6.
3. Spiers ASD, Perekh SJ, Bishop MB. Hairy cell leukemia: induction of complete remission with pentostatin (2 deoxycoformicin). J Clin Oncol 1984; 2: 1336-42.
4. Piro LD, Carrera CJ, Carson DA, Beutler E. Lasting remission in hairy cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine. N Engl J Med 1990; 322: 1117-21.
5. Saven A, Piro LD. Treatment of Hairy cell Leukemia. Blood 1992: 79: 1111-1120.
6. Beutler E, Piro LD, Saven A. 2CdA: a potent chemotherapeutic and immunosuppressive nucleoside. Leuk Lymph 1991; 5: 1-8.
7. Hounieu H, Chittal SM, AI Saati T et al. Hairy cell leukemia. Diagnosis of bone marrow involvement in paraffin-embedded sections by monoclonal antibody DBA 44. Am J Clin Pathol 1992; 98: 26-33.
8. Delsol G, Al Saati T, Brousset P et al. New anti-«leukocyte antibodies for immunophenotyping malignant lymphomas on paraffin sections. Paper presented at Symposium on the biology of human malignant lymphomas, Bordeaux 1990; 55.
9. Saven A, Piro LD. 2-Chlorodeoxyadenosine in the treatment of hairy cell leukemia. Cancer Invest 1993; 11: 559-64.
10. Raemaekers M, vtVeer G, Verhoef P et al. Two hour i.v. infusion of 2 Chlorodeoxyadenosine (2CdA) in Hairy Cell Leukemia (HCL) is effective and may produce less CD4/CD8 ratio impairment . Results from HOVON 23 Study. Blood 1995; 86: (suppl 1) 351a; Abstr 1382.
11. Juliusson G, Heldal D, Hipps E et al. Subcutaneous injections of Chlorodeoxyadenosine for symptomatic hairy cell leukemia. J Clin Oncol 1995; 13: 989-95.
12. van Rohr A, Bacchi M, Fey MF et al. 2-Chlorodeoxyadenosine (CdA) by subcutaneous bolus injection: a phase II study on hairy cell leukemia (HCL). Blood 1995; 86: (suppl 1) 350a; Abstr 1386.
13. Robak T, Blasinka-Morawiec M, Krykowski E et al. 2-Chlorodeoxyadenosine (2-CdA) in 2-hour versus 24-hour intravenous infusion in the treatment of patients with hairy cell leukemia. Leuk Lymph 1996; 22: 107-11.
14. Seymour JF, Kurzrock R, Freireich EJ et al. 2-Chlorodeoxyadenosine induces durable remissions and prolonged suppression of CdA lymphocytes in patients wih hairy cell leukemia. Blood 1993; 83: 1798-802.
15. Huffman M, Janson A, Aggarwal A, Rai KR. Long term results after treatment of hairy cell leukemia (HCL) with 2-Chlorodeoxyadenosine (2CdA). Blood 1995; 86: (suppl 1) 351a; Abstr 1393.
16. Lauria F, Salvucci M, Rondelli D et al. Weekly administration of 2-Chlorodeoxyadenosine is safe and still effective in HCL patients. Blood 1995; 86: (suppl 1) 837a; Abstr 3336.